This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Baxter International Inc.
Drug Names(s): Recombinant Human Insulin Inhalation Powder, Inhaled Insulin
Description: RHIIP is a pulmonary insulin produced with Baxter’s PROMAXX microsphere technology and administered using a small, standard dry powder inhaler.
Additional information available to subscribers only: